A 56-year-old with hypertriglyceridemia (TG 620 mg/dL) and pancreatitis risk is on maximally tolerated statin; secondary causes addressed. Next best t...

Question

A 56-year-old with hypertriglyceridemia (TG 620 mg/dL) and pancreatitis risk is on maximally tolerated statin; secondary causes addressed. Next best therapy to reduce pancreatitis risk?

Accepted Answer

PCSK9 inhibitor

Answer

Ezetimibe

Answer

Icosapent ethyl 2 g BID

Answer

Niacin high dose

Answer

Fibrate (fenofibrate)

us-abim MCQ (SBA): Hypertriglyceridemia

A 56-year-old with hypertriglyceridemia (TG 620 mg/dL) and pancreatitis risk is on maximally tolerated statin; secondary causes addressed. Next best therapy to reduce pancreatitis risk?